A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer

Closed

Phase

Accrual

100%

Published

Abbreviated Title

Gemcitabine + CDDP in SCLC

Activated

07/01/1998

Closed

06/15/1999

Research committees

Lung Cancer

Publication Information Expand/Collapse

2007

Phase II Study of Gemcitabine and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group Study 9718 [PMID: 17473660]

PJ Hesketh;K Chansky;V Israel;RT Grapski;TM Mekhail;CH Spiridonidis;GM Mills;K Kelly;JJ Crowley;DR Gandara Journal of Thoracic Oncology 2(5):440-444

2001

Southwest Oncology Group trial (SWOG) S9718: a phase II study of gemcitabine plus cisplatin in patients with extensive small cell lung cancer (E-SCLC)

VP Israel;K Chansky;D Gandara Proc of the American Society of Clinical Oncology 20:316a(#1262)

2000

Gemcitabine and platinum combinations in advanced non-small cell lung cancer: an update

DR Gandara;MJ Edelman;P Lara;D Lau Lung Cancer 29(Suppl.2):7

Other Clinical Trials

SWOG Clinical Trial Number

S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER

Research Committee(s)

Lung Cancer

Activated

03/06/2023

Accrual

68%

Open

Phase

SWOG Clinical Trial Number

A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

12/21/2021

Open

Phase

SWOG Clinical Trial Number

CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Research Committee(s)

Lung Cancer

Activated

08/17/2020

Open